Terry J. DuBose, M.S. - Chairman USA
Gregrio Lorenzo Accio, MS - Brazil
Joan P. Baker MSR - USA
David E. Blackwell, MD - USA
Professor Pavel Calda, MD, PhD - Czech Republic
Joshua Abbott Copel, MD - USA
Greggory R. DeVore, MD - USA
Jeffrey M. Dicke, MD - USA
Julia Drose, BA - USA
Arthur C. Fougner, MD - USA
David Ashley Hill, MD - USA
David Hutchon, BSc, MB, ChB, FRCOG Scotland
Alicia M. Lapidus, MD - Argentina
Edward A. Lyons, MD - Canada
Daniel Margulies, MD - Argentina
Martin Necas, RDMS, RVT - New Zealand
Wayne H. Persutte, BS, RDMS - USA
Lawrence David Platt, MD - USA
Cindy Rapp, RDMS - USA
Johannes Wilhelm 'Hans' van der Slikke, MD, PhD - Netherlands
James S Smeltzer, MD - USA
Ilan E. Timor-Tritsch, MD - USA
Master Sgt. Cheryl Vance, MA, RDMS, RVT - USA
Professor Anthony M. Vintzileos, MD - USA
Christopher Ross Welsh, MD, MRCOG - UK
Josef Wisser, MD - Switzerland
Joseph A Worrall MD RDMS - USA
Edward M. Zabrek, MD - USA
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
FDA grants Priority Review to flibanserin for treating postmenopausal HSDD
July 24th 2025The FDA has granted Priority Review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.
Read More